The valuation of the Refractive Surgery Device Market is anticipated to reach USD 213.0 million by the year 2024, with a projected CAGR of 3.90% during the forecast period of 2024 to 2034. It is expected that the global market will offer an absolute dollar opportunity of USD 312.3 million by the end of 2034.
This growth can be attributed to the increasing number of elderly individuals and the rise in screen time due to Covid-19 restrictions.
Key Market Drivers
Positive outcomes and high satisfaction rates among patients who undergo refractive surgeries encourage more individuals to consider these procedures. This has pushed the demand for refractive surgery devices in the general population.
Apart from this, several other reasons are responsible for the growth of the refractive surgery devices market in the past few years:
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2024) | USD 213.0 million |
Anticipated Forecast Value (2034) | USD 312.3 million |
Estimated Growth (2024 to 2034) | 3.90% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global refractive surgery devices market is witnessing several notable trends that are shaping its trajectory in recent years:
Despite significant technological advancements in refractive surgeries, there are several factors that are hindering the widespread adoption of these procedures and limiting the growth of the market.
On the basis of product, the market for refractive surgery devices is segmented into Lasers, microkeratome, aberrometers, etc. The lasers category, accounting for 48%, is projected to hold the largest share of the global refractive surgery device market in 2024.
Attributes | Details |
---|---|
Product | Lasers |
Market Share | 48.00% |
With a share of 38%, hospitals dominate the refractive surgery device market based on their end-use.
Attributes | Details |
---|---|
End-use | Hospitals |
Market Share | 38% |
This section offers a comprehensive analysis of the refractive surgery device market across various countries, including India, Thailand, Malaysia, Indonesia, and Spain. The table presents the CAGR for each country, depicting the estimated market growth in these regions until 2034.
Countries | CAGR |
---|---|
India | 5.40% |
Thailand | 4.70% |
Malaysia | 4.20% |
Indonesia | 4.00% |
Spain | 3.60% |
India is expected to exhibit significant market growth over the forecast period. The Indian market for refractive surgery devices is anticipated to grow at a CAGR of 5.40% through 2034.
The refractive surgery device market in India is on the rise, driven by a large population with a high prevalence of refractive errors. India also has an impressive healthcare infrastructure, with several hospitals and clinics equipped with state-of-the-art laser devices and skilled ophthalmic surgeons. This factor makes it a preferred destination for domestic and international patients seeking cost-effective and high-quality vision correction procedures.
Thailand is also one of the lucrative markets in the refractive surgery devices industry. The Thai market for refractive surgery devices is anticipated to grow at a CAGR of 4.70%.
Thailand's refractive surgery device market is fueled by its well-established medical tourism industry. The country attracts a large number of international patients seeking affordable yet high-quality healthcare services, including refractive surgeries. Thailand's advanced healthcare infrastructure, modern facilities, and internationally trained medical professionals make it an attractive destination for medical tourists from neighboring countries and beyond.
Malaysia also is a promising market in the global refractive surgery devices industry. Over the next ten years, the Malaysian demand for refractive surgery devices is projected to rise at a 4.20% CAGR.
Malaysia is quickly becoming a hub for refractive surgeries due to its strategic location, advanced healthcare facilities, and growing medical tourism industry. The country offers a safe and comfortable environment for patients seeking vision correction procedures, with a range of internationally accredited hospitals and specialized eye care centers equipped with cutting-edge refractive surgery devices. Malaysia's healthcare costs are affordable, and English-speaking healthcare professionals are readily available.
Indonesia is also one of the countries that is filled with potential in this market. The Indonesian refractive surgery device market is anticipated to retain its dominance by progressing at a growth rate of 4.00% till 2034.
The refractive surgery device market in Indonesia is expanding due to its large and increasingly affluent population, growing healthcare expenditures, and rising demand for vision correction procedures. Indonesian government's initiatives to improve healthcare access and quality, coupled with the rising awareness of refractive surgery options among the population, contribute to the country's growing prominence in the market.
Spain also exhibits a promising future in the global refractive surgery devices market. The refractive surgery device market in Spain is anticipated to retain its dominance by progressing at a growth rate of 3.60% till 2034.
Spain's well-established ophthalmic research and innovation ecosystem drive the development and adoption of cutting-edge refractive surgery devices and techniques. With its modern healthcare infrastructure, regulatory compliance, and expertise in ophthalmology, Spain continues to attract patients seeking safe, effective, and affordable vision correction procedures.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Due to their prolonged presence, the market for refractive surgery devices is filled with companies with a strong foothold in the international marketplace. Hospitals, ambulatory surgical centers, and emergency clinics rely on these companies for the devices required for refractive surgeries.
Some of the most prominent companies in the market are Alcon Inc., Carl Zeiss Meditec AG, Johnson & Johnson Vision, Bausch + Lomb, NIDEK Co., Ltd., and Ziemer Ophthalmic Systems AG. These companies invest billions of dollars to come up with new technologies to make the surgery process more convenient, effective, and less time-consuming.
Recent Developments
The refractive surgery device market is expected to be worth USD 213 million by 2024.
The market for refractive surgery devices is expected to reach USD 312.30 million by 2034.
The refractive surgery device market is growing at a CAGR of 3.90% from 2024 to 2034.
Alcon Inc., Carl Zeiss Meditec AG, Johnson & Johnson Vision, Bausch + Lomb, NIDEK Co., Ltd, etc., are some of the major players in the market for refractive surgery devices.
The valuation for the refractive surgery device market in 2018 was USD 181.1 million.
Estimated Market Size (2024E) | USD 1,850.3 million |
---|---|
Projected Market Value (2034F) | USD 3,440.8 million |
Value-based CAGR (2024 to 2034) | 6.4% |
Market Value for 2024 | USD 8,928 million |
---|---|
Market Value for 2034 | USD 12,472.70 million |
Market Forecast CAGR for 2024 to 2034 | 3.40% |
Explore Therapeutic Device Insights
View ReportsThank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.